Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): Report from the national heart, lung, and blood institute PTCA registry

The NHLBI PTCA Registry has collected data from 3,079 patients who underwent PTCA at 105 centers from September 1977 through September 1981 that document the initial risks and benefits of PTCA. A subgroup of 2,272 patients at 65 centers was chosen to examine the long-term effects of PTCA (97% follow...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 1984-06, Vol.53 (12), p.C27-C31
Hauptverfasser: Kent, Kenneth M., Bentivoglio, Lamberto G., Block, Peter C., Bourassa, Martial G., Cowley, Michael J., Dorros, Gerald, Detre, Katherine M., Gosselin, Arthur J., Gruentzig, Andreas R., Kelsey, Sheryl F., Mock, Michael B., Mullin, Suzanne M., Passamani, Eugene R., Myler, Richard K, Simpson, John, Stertzer, Simon H., Van Raden, Mark J., O. Williams, David
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page C31
container_issue 12
container_start_page C27
container_title The American journal of cardiology
container_volume 53
creator Kent, Kenneth M.
Bentivoglio, Lamberto G.
Block, Peter C.
Bourassa, Martial G.
Cowley, Michael J.
Dorros, Gerald
Detre, Katherine M.
Gosselin, Arthur J.
Gruentzig, Andreas R.
Kelsey, Sheryl F.
Mock, Michael B.
Mullin, Suzanne M.
Passamani, Eugene R.
Myler, Richard K
Simpson, John
Stertzer, Simon H.
Van Raden, Mark J.
O. Williams, David
description The NHLBI PTCA Registry has collected data from 3,079 patients who underwent PTCA at 105 centers from September 1977 through September 1981 that document the initial risks and benefits of PTCA. A subgroup of 2,272 patients at 65 centers was chosen to examine the long-term effects of PTCA (97% follow-up). All patients were followed for 1 year, 191 for 3 years and 57 for 4 years. Initial success occurred in 1,397 (61%), and 72% remained improved at 1 year with no further procedures; during the first year of follow-up, 14% had repeat PTCA, 12% had CABG, 3% had MI and 1.6% died. After 1 year, 67% were asymptomatic; of these, 52% had no other procedure, 7% had a second PTCA and 8% had CABG. Follow-up at 2 to 4 years was similar except that there were few repeat PTCA or CABG procedures after 1 year. The annual mortality rate after PTCA in patients with 1-vessel diseases was less than 1% per year and with multivessel CAD, 3% per year. Thus, successful PTCA alone results in sustained improvement in 84% of patients; 59% were asymptomatic (12% had repeat PTCA). PTCA offers extended effective therapy in selected patients with CAD.
doi_str_mv 10.1016/0002-9149(84)90741-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_81102326</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0002914984907410</els_id><sourcerecordid>81102326</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-33bd54f81164d974c222a26b832bed675e54d98be335dd5929b66059546450653</originalsourceid><addsrcrecordid>eNp9UduKFDEQDaKs4-ofKORJdmFbc59uH4Rl8AYDiqzPIZ1Uz0a6kzZJC_MffrBpZ9hHn4qqOudU1SmEXlLyhhKq3hJCWNNR0V214rojW0Eb8ghtaLvtGtpR_hhtHiBP0bOcf9aUUqku0IVinLct26A_-xgOTYE0YRgGb4094jjgGZJdigkQl4xLMiGPy-SDGbGNKQaTjtiEg4_zaHI54qtvd7vb63f4O8wxFTykOOFyDziY4uPKugeTyg0el3C4qUyH-zFGh33IxZelAF4FcIKDzyUdn6MngxkzvDjHS_Tj44e73edm__XTl93tvrF1-9Jw3jsphpZSJVy3FZYxZpjqW856cGorQdZ62wPn0jnZsa5XishOCiUkUZJfotcn3TnFXwvkoiefLYzj6XBdlQnjTFWgOAFtijknGPSc_FRd0JTo9Rl6dVqvTutW6H_P0KTSXp31l34C90A6u1_77099qEf-9pB0th6CBecT2KJd9P8f8Bfkgpl8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81102326</pqid></control><display><type>article</type><title>Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): Report from the national heart, lung, and blood institute PTCA registry</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kent, Kenneth M. ; Bentivoglio, Lamberto G. ; Block, Peter C. ; Bourassa, Martial G. ; Cowley, Michael J. ; Dorros, Gerald ; Detre, Katherine M. ; Gosselin, Arthur J. ; Gruentzig, Andreas R. ; Kelsey, Sheryl F. ; Mock, Michael B. ; Mullin, Suzanne M. ; Passamani, Eugene R. ; Myler, Richard K ; Simpson, John ; Stertzer, Simon H. ; Van Raden, Mark J. ; O. Williams, David</creator><creatorcontrib>Kent, Kenneth M. ; Bentivoglio, Lamberto G. ; Block, Peter C. ; Bourassa, Martial G. ; Cowley, Michael J. ; Dorros, Gerald ; Detre, Katherine M. ; Gosselin, Arthur J. ; Gruentzig, Andreas R. ; Kelsey, Sheryl F. ; Mock, Michael B. ; Mullin, Suzanne M. ; Passamani, Eugene R. ; Myler, Richard K ; Simpson, John ; Stertzer, Simon H. ; Van Raden, Mark J. ; O. Williams, David</creatorcontrib><description>The NHLBI PTCA Registry has collected data from 3,079 patients who underwent PTCA at 105 centers from September 1977 through September 1981 that document the initial risks and benefits of PTCA. A subgroup of 2,272 patients at 65 centers was chosen to examine the long-term effects of PTCA (97% follow-up). All patients were followed for 1 year, 191 for 3 years and 57 for 4 years. Initial success occurred in 1,397 (61%), and 72% remained improved at 1 year with no further procedures; during the first year of follow-up, 14% had repeat PTCA, 12% had CABG, 3% had MI and 1.6% died. After 1 year, 67% were asymptomatic; of these, 52% had no other procedure, 7% had a second PTCA and 8% had CABG. Follow-up at 2 to 4 years was similar except that there were few repeat PTCA or CABG procedures after 1 year. The annual mortality rate after PTCA in patients with 1-vessel diseases was less than 1% per year and with multivessel CAD, 3% per year. Thus, successful PTCA alone results in sustained improvement in 84% of patients; 59% were asymptomatic (12% had repeat PTCA). PTCA offers extended effective therapy in selected patients with CAD.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/0002-9149(84)90741-0</identifier><identifier>PMID: 6233882</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Angioplasty, Balloon - adverse effects ; Coronary Artery Bypass ; Coronary Disease - mortality ; Coronary Disease - surgery ; Coronary Disease - therapy ; Coronary Vessels ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Myocardial Infarction - etiology ; National Institutes of Health (U.S.) ; Registries ; United States</subject><ispartof>The American journal of cardiology, 1984-06, Vol.53 (12), p.C27-C31</ispartof><rights>1984</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c338t-33bd54f81164d974c222a26b832bed675e54d98be335dd5929b66059546450653</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0002914984907410$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6233882$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kent, Kenneth M.</creatorcontrib><creatorcontrib>Bentivoglio, Lamberto G.</creatorcontrib><creatorcontrib>Block, Peter C.</creatorcontrib><creatorcontrib>Bourassa, Martial G.</creatorcontrib><creatorcontrib>Cowley, Michael J.</creatorcontrib><creatorcontrib>Dorros, Gerald</creatorcontrib><creatorcontrib>Detre, Katherine M.</creatorcontrib><creatorcontrib>Gosselin, Arthur J.</creatorcontrib><creatorcontrib>Gruentzig, Andreas R.</creatorcontrib><creatorcontrib>Kelsey, Sheryl F.</creatorcontrib><creatorcontrib>Mock, Michael B.</creatorcontrib><creatorcontrib>Mullin, Suzanne M.</creatorcontrib><creatorcontrib>Passamani, Eugene R.</creatorcontrib><creatorcontrib>Myler, Richard K</creatorcontrib><creatorcontrib>Simpson, John</creatorcontrib><creatorcontrib>Stertzer, Simon H.</creatorcontrib><creatorcontrib>Van Raden, Mark J.</creatorcontrib><creatorcontrib>O. Williams, David</creatorcontrib><title>Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): Report from the national heart, lung, and blood institute PTCA registry</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>The NHLBI PTCA Registry has collected data from 3,079 patients who underwent PTCA at 105 centers from September 1977 through September 1981 that document the initial risks and benefits of PTCA. A subgroup of 2,272 patients at 65 centers was chosen to examine the long-term effects of PTCA (97% follow-up). All patients were followed for 1 year, 191 for 3 years and 57 for 4 years. Initial success occurred in 1,397 (61%), and 72% remained improved at 1 year with no further procedures; during the first year of follow-up, 14% had repeat PTCA, 12% had CABG, 3% had MI and 1.6% died. After 1 year, 67% were asymptomatic; of these, 52% had no other procedure, 7% had a second PTCA and 8% had CABG. Follow-up at 2 to 4 years was similar except that there were few repeat PTCA or CABG procedures after 1 year. The annual mortality rate after PTCA in patients with 1-vessel diseases was less than 1% per year and with multivessel CAD, 3% per year. Thus, successful PTCA alone results in sustained improvement in 84% of patients; 59% were asymptomatic (12% had repeat PTCA). PTCA offers extended effective therapy in selected patients with CAD.</description><subject>Angioplasty, Balloon - adverse effects</subject><subject>Coronary Artery Bypass</subject><subject>Coronary Disease - mortality</subject><subject>Coronary Disease - surgery</subject><subject>Coronary Disease - therapy</subject><subject>Coronary Vessels</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - etiology</subject><subject>National Institutes of Health (U.S.)</subject><subject>Registries</subject><subject>United States</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UduKFDEQDaKs4-ofKORJdmFbc59uH4Rl8AYDiqzPIZ1Uz0a6kzZJC_MffrBpZ9hHn4qqOudU1SmEXlLyhhKq3hJCWNNR0V214rojW0Eb8ghtaLvtGtpR_hhtHiBP0bOcf9aUUqku0IVinLct26A_-xgOTYE0YRgGb4094jjgGZJdigkQl4xLMiGPy-SDGbGNKQaTjtiEg4_zaHI54qtvd7vb63f4O8wxFTykOOFyDziY4uPKugeTyg0el3C4qUyH-zFGh33IxZelAF4FcIKDzyUdn6MngxkzvDjHS_Tj44e73edm__XTl93tvrF1-9Jw3jsphpZSJVy3FZYxZpjqW856cGorQdZ62wPn0jnZsa5XishOCiUkUZJfotcn3TnFXwvkoiefLYzj6XBdlQnjTFWgOAFtijknGPSc_FRd0JTo9Rl6dVqvTutW6H_P0KTSXp31l34C90A6u1_77099qEf-9pB0th6CBecT2KJd9P8f8Bfkgpl8</recordid><startdate>19840615</startdate><enddate>19840615</enddate><creator>Kent, Kenneth M.</creator><creator>Bentivoglio, Lamberto G.</creator><creator>Block, Peter C.</creator><creator>Bourassa, Martial G.</creator><creator>Cowley, Michael J.</creator><creator>Dorros, Gerald</creator><creator>Detre, Katherine M.</creator><creator>Gosselin, Arthur J.</creator><creator>Gruentzig, Andreas R.</creator><creator>Kelsey, Sheryl F.</creator><creator>Mock, Michael B.</creator><creator>Mullin, Suzanne M.</creator><creator>Passamani, Eugene R.</creator><creator>Myler, Richard K</creator><creator>Simpson, John</creator><creator>Stertzer, Simon H.</creator><creator>Van Raden, Mark J.</creator><creator>O. Williams, David</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19840615</creationdate><title>Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): Report from the national heart, lung, and blood institute PTCA registry</title><author>Kent, Kenneth M. ; Bentivoglio, Lamberto G. ; Block, Peter C. ; Bourassa, Martial G. ; Cowley, Michael J. ; Dorros, Gerald ; Detre, Katherine M. ; Gosselin, Arthur J. ; Gruentzig, Andreas R. ; Kelsey, Sheryl F. ; Mock, Michael B. ; Mullin, Suzanne M. ; Passamani, Eugene R. ; Myler, Richard K ; Simpson, John ; Stertzer, Simon H. ; Van Raden, Mark J. ; O. Williams, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-33bd54f81164d974c222a26b832bed675e54d98be335dd5929b66059546450653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Angioplasty, Balloon - adverse effects</topic><topic>Coronary Artery Bypass</topic><topic>Coronary Disease - mortality</topic><topic>Coronary Disease - surgery</topic><topic>Coronary Disease - therapy</topic><topic>Coronary Vessels</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - etiology</topic><topic>National Institutes of Health (U.S.)</topic><topic>Registries</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kent, Kenneth M.</creatorcontrib><creatorcontrib>Bentivoglio, Lamberto G.</creatorcontrib><creatorcontrib>Block, Peter C.</creatorcontrib><creatorcontrib>Bourassa, Martial G.</creatorcontrib><creatorcontrib>Cowley, Michael J.</creatorcontrib><creatorcontrib>Dorros, Gerald</creatorcontrib><creatorcontrib>Detre, Katherine M.</creatorcontrib><creatorcontrib>Gosselin, Arthur J.</creatorcontrib><creatorcontrib>Gruentzig, Andreas R.</creatorcontrib><creatorcontrib>Kelsey, Sheryl F.</creatorcontrib><creatorcontrib>Mock, Michael B.</creatorcontrib><creatorcontrib>Mullin, Suzanne M.</creatorcontrib><creatorcontrib>Passamani, Eugene R.</creatorcontrib><creatorcontrib>Myler, Richard K</creatorcontrib><creatorcontrib>Simpson, John</creatorcontrib><creatorcontrib>Stertzer, Simon H.</creatorcontrib><creatorcontrib>Van Raden, Mark J.</creatorcontrib><creatorcontrib>O. Williams, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kent, Kenneth M.</au><au>Bentivoglio, Lamberto G.</au><au>Block, Peter C.</au><au>Bourassa, Martial G.</au><au>Cowley, Michael J.</au><au>Dorros, Gerald</au><au>Detre, Katherine M.</au><au>Gosselin, Arthur J.</au><au>Gruentzig, Andreas R.</au><au>Kelsey, Sheryl F.</au><au>Mock, Michael B.</au><au>Mullin, Suzanne M.</au><au>Passamani, Eugene R.</au><au>Myler, Richard K</au><au>Simpson, John</au><au>Stertzer, Simon H.</au><au>Van Raden, Mark J.</au><au>O. Williams, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): Report from the national heart, lung, and blood institute PTCA registry</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>1984-06-15</date><risdate>1984</risdate><volume>53</volume><issue>12</issue><spage>C27</spage><epage>C31</epage><pages>C27-C31</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>The NHLBI PTCA Registry has collected data from 3,079 patients who underwent PTCA at 105 centers from September 1977 through September 1981 that document the initial risks and benefits of PTCA. A subgroup of 2,272 patients at 65 centers was chosen to examine the long-term effects of PTCA (97% follow-up). All patients were followed for 1 year, 191 for 3 years and 57 for 4 years. Initial success occurred in 1,397 (61%), and 72% remained improved at 1 year with no further procedures; during the first year of follow-up, 14% had repeat PTCA, 12% had CABG, 3% had MI and 1.6% died. After 1 year, 67% were asymptomatic; of these, 52% had no other procedure, 7% had a second PTCA and 8% had CABG. Follow-up at 2 to 4 years was similar except that there were few repeat PTCA or CABG procedures after 1 year. The annual mortality rate after PTCA in patients with 1-vessel diseases was less than 1% per year and with multivessel CAD, 3% per year. Thus, successful PTCA alone results in sustained improvement in 84% of patients; 59% were asymptomatic (12% had repeat PTCA). PTCA offers extended effective therapy in selected patients with CAD.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>6233882</pmid><doi>10.1016/0002-9149(84)90741-0</doi></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 1984-06, Vol.53 (12), p.C27-C31
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_81102326
source MEDLINE; Elsevier ScienceDirect Journals
subjects Angioplasty, Balloon - adverse effects
Coronary Artery Bypass
Coronary Disease - mortality
Coronary Disease - surgery
Coronary Disease - therapy
Coronary Vessels
Female
Follow-Up Studies
Humans
Male
Middle Aged
Myocardial Infarction - etiology
National Institutes of Health (U.S.)
Registries
United States
title Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): Report from the national heart, lung, and blood institute PTCA registry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T22%3A59%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20efficacy%20of%20percutaneous%20transluminal%20coronary%20angioplasty%20(PTCA):%20Report%20from%20the%20national%20heart,%20lung,%20and%20blood%20institute%20PTCA%20registry&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Kent,%20Kenneth%20M.&rft.date=1984-06-15&rft.volume=53&rft.issue=12&rft.spage=C27&rft.epage=C31&rft.pages=C27-C31&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/0002-9149(84)90741-0&rft_dat=%3Cproquest_cross%3E81102326%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=81102326&rft_id=info:pmid/6233882&rft_els_id=0002914984907410&rfr_iscdi=true